Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Classical molecular drug targets collectively refer to the four major classes of macromolecules—enzymes, G protein-coupled receptors, ion channels, and transporters—that constitute the primary focus for the majority of approved and experimental drugs[8][1]. These protein families are highly studied since their modulation can influence key biological processes such as metabolism, cell signaling, and ion transport, which in turn play central roles in various diseases. The term is generic and does not correspond to a specific protein or gene but rather groups a set of well-validated molecular entities that serve as the cornerstone of traditional pharmacology and drug development[8][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Classical Molecular Drug Targets.